Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature.
about
Clinical manifestations and management of Gaucher diseaseA Review of Gaucher Disease Pathophysiology, Clinical Presentation and TreatmentsHematological manifestations and complications of Gaucher disease.A double-blind, randomized, placebo-controlled trial studying the effects of Saccharomyces boulardii on the gastrointestinal tolerability, safety, and pharmacokinetics of miglustat.Once again, rare diseases provide a spotlight.Fabry disease: Four case reports of meningioma and a review of the literature on other malignanciesModelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications.Severe impairment of regulatory T-cells and Th1-lymphocyte polarization in patients with Gaucher disease.Evaluation of disease burden and response to treatment in adults with type 1 Gaucher disease using a validated disease severity scoring system (DS3)Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patientsTreatment of lysosomal storage disorders: successes and challenges.Gaucher disease and bone manifestations.Gaucher disease: Progress and ongoing challenges.Iron storage in liver, bone marrow and splenic Gaucheroma reflects residual disease in type 1 Gaucher disease patients on treatment.Hepatocellular carcinoma in Gaucher disease: an international case series.MGUS, lymphoplasmacytic malignancies and Gaucher disease: the significance of the clinical association.Type I Gaucher disease with bullous pemphigoid and Parkinson disease: A case report.Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously.Gaucher disease
P2860
Q26775747-0E9A17D6-D475-4FD5-B535-FD40B02A0794Q30235844-23F0D037-97C1-4D7B-A46D-55A8D2466BF8Q33427535-FF81E8D6-34F2-4313-9D33-0D2F03C6B174Q33465330-090C245A-E398-4E0D-ADA1-889CCB329069Q33731837-78B1626B-867D-4BF1-B43F-F30552117990Q33798230-4E0930E3-11D6-49CD-B7BD-EE6385A1E356Q34485240-00D27541-0774-4166-A671-9CE7B57D8567Q35183107-CC1D4BAB-F663-4A16-B08A-5E10C2AB38BEQ35754621-1B4A7BC2-3A6C-4003-BD6A-8B822CC84B37Q36725221-26BF8ABD-8B29-4926-8CC1-954B563E1867Q38211269-C4EF5C97-C2DC-49DD-8F20-C5D4A90478F1Q38265941-062990B4-EAD2-4094-B957-8CB172027BAEQ39028972-248C02A4-2C94-4023-B2E2-51EBC1937A41Q47805142-E4028424-DE87-47A2-AB54-387E233BE17FQ48501252-96AD644D-A58F-47A0-8911-56E15C4D5C3DQ52591049-D9C1C7EC-C51D-4B6E-8685-40352D713F17Q52622921-D1A18BEA-861B-4C68-8B67-9DA0E6873B86Q54111080-838ACF65-B299-4C56-BFE0-BC2C38A53B59Q56338451-BF4E137D-2300-420E-A116-87A57D423E48
P2860
Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Malignancies and monoclonal ga ...... atic review of the literature.
@ast
Malignancies and monoclonal ga ...... atic review of the literature.
@en
Malignancies and monoclonal ga ...... atic review of the literature.
@nl
type
label
Malignancies and monoclonal ga ...... atic review of the literature.
@ast
Malignancies and monoclonal ga ...... atic review of the literature.
@en
Malignancies and monoclonal ga ...... atic review of the literature.
@nl
prefLabel
Malignancies and monoclonal ga ...... atic review of the literature.
@ast
Malignancies and monoclonal ga ...... atic review of the literature.
@en
Malignancies and monoclonal ga ...... atic review of the literature.
@nl
P2093
P2860
P356
P1476
Malignancies and monoclonal ga ...... atic review of the literature.
@en
P2093
Carla E M Hollak
Laura van Dussen
Maarten Arends
Marieke Biegstraaten
P2860
P304
P356
10.1111/BJH.12335
P407
P577
2013-04-18T00:00:00Z